Stay updated on PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.

Latest updates to the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new information about a clinical study on PD-1 antibody combined with COX inhibitor for colorectal cancer, while significant details about previous findings and study criteria have been removed.SummaryDifference32%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.